INTRODUCTION
The production of neutrophils and mononuclear phagocytes in clonal cultures of human bone marrow cells is dependent upon a family of regulatory glyReceived for publication 28 June 1982 and in revised form 14 October 1982. coproteins known as granulocyte-monocyte colonystimulating activity (CSA)' (1) (2) (3) . CSA is produced by a variety of normal cell types including mononuclear phagocytes (4) (5) (6) , T lymphocytes (6-8)-, and vascular endothelial cells (9, 10) .2 Murine fibroblast cell-lines produce CSA (11) , but recent reports suggest that neither human nor murine bone marrow-derived (12) (13) (14) (15) or skin-derived (15) fibroblasts produce CSA in culture. We have recently described a soluble factor produced by mononuclear phagocytes that stimulates CSA production by T lymphocytes (6) and endothelial cells. 2 The latter two cell types produce little CSA in culture unless they are stimulated with exogenous factors such as mitogens (6, 7) , endotoxin (10) , or a monokine (6) . 2 The potential physiological significance of the monokine is further supported by our observation that its production or release is inhibited by low concentrations of lactoferrin (6) , a putative feedback regulator of granulopoiesis (16, 17) . We now describe experiments that demonstrate that skin-derived human fibroblasts can produce CSA when stimulated by a soluble factor released by mononuclear phagocytes, and that the production and/or release of the regulatory monokine is inhibited by lactoferrin. ' Abbreviations used in this paper: CSA, granulocytemonocyte colony-stimulating activity; FCM, fibroblast-conditioned medium; FCMM, conditioned medium from fibroblasts cultured in MCM; FCMMLF, conditioned medium from fibroblasts cultured in conditioned medium from monocytes cultured in medium containing 1012 M lactoferrin; FCMLFM, conditioned medium from fibroblasts cultured METHODS Fibroblast cultures. Human skin fibroblasts obtained from explants of neonatal foreskin were prepared according to previously described techniques (18 24 h in McCoy's 5A medium lacking unlabeled proline and glycine and containing tritiated proline and glycine (10,gCi/ml), 10% human serum, 100 U/ml of penicillin, and 100 Ag/ml of streptomycin. The cell layer was scraped from the flask with the medium, pooled, and lyophilized. The lyophilized samples along with carrier collagen were digested with CNBr in 70% formic acid. The resulting radioactive peptides were separated by chromatography as previously described (19) . These cells produced 85-90% type I and 10-15% type III collagen. Collagen represented 15% of the total protein produced by these cells in vitro.
All experiments were performed by using cells between the third and eighth subculture, with the cells in the late logarithmic phase of growth. The doubling time of these cells ranged from 22 to 24 h. Cells were incubated either in RPMI 1640 with 15% lactoferrin-depleted fetal calf serum (FCS) or in a variety of monocyte-conditioned media (MCM) at 370C for 3 d. The resulting fibroblast-conditioned media (FCM) were tested for CSA in the granulocyte colony-growth assay described below.
Mononuclear phagocytes. Monocytes were isolated from peripheral blood mononuclear leukocytes of normal volunteers as previously described (6) by adherence to serumcoated dishes. The adherent cells, which were detached from the dishes with 0.02% EDTA, were >90% alpha napthyl butyrate esterase-positive. These monocytes were resuspended at a concentration of 2-3 X 105/ml in RPMI 1640 (Gibco Laboratories, Grand Island Biological Co., Grand Island, NY) supplemented with 15% lactoferrin-depleted FCS, and incubated for [3] [4] [5] d at 370C in a 7.5% CO2 atmosphere. Monocytes were also cultured in the presence of 10-12 M human breast-milk lactoferrin as previously described (6, 18) . The MCM harvested on the final day of culture was diluted 1:1 with complete RPMI medium and was used to replace the fibroblast culture medium (see above). The supernatants of fibroblasts cultured with MCM (FCMM) and without MCM (FCM) were harvested after incubation at 37°C for 3 d and tested for CSA at concentrations of 5 and 10% in the colony growth assay. In two experiments, monocytes ranging from 102/ml to 106/ml were used in culture to generate conditioned media that were harvested after 3 d of culture for CSA assays and fibroblast cultures. Conditioned medium (50%) from monocytes cultured in 10-12 M lactoferrin was also used in three fibroblast culture experiments. The activity of the resultant FCMMLF was compared with that of conditioned medium of fibroblasts cultured in MCM to which lactoferrin (10-12 M) had been added. MCM (Fig. 1) . Colony growth stimulated by FCMM vs. MCM or FCM was significantly different (P < 0.001) in all experiments (t tests), and mean colony growth/105 cells for the group of experiments was significantly greater when cultures were stimulated by FCMM (P < 0.001). Thus, supernatants of fibroblasts cultured for 3 d in MCM contained more CSA than supernatants of fibroblasts or monocytes cultured in medium alone (Fig. 1) . This effect of MCM required intact fibroblasts because mixtures of FCM and MCM contained no more CSA than FCM or MCM alone (data not shown). The stimulatory activity in MCM was readily detectable in the 3-d supernatant medium of 103 monocytes/ ml that was devoid of CSA (Table I) .
The (Fig. 2) .
DISCUSSION
Recent studies using long-term marrow cell culture techniques (21) have documented that fibroblasts derived from murine marrow augment survival of hemopoietic stem cells (13, 14) . However, although murine fibroblast cell-lines produce CSA (11) , a number of groups have failed to detect CSA in conditioned media of either murine (13, 14) or human (12, 15) We had previously demonstrated that soluble factors released from mononuclear phagocytes stimulate T lymphocytes and endothelial cells (6)2 to produce large amounts of CSA. Moreover, mononuclear phagocytes are known to facilitate proliferation of both fibroblasts (22, 23) and endothelial cells (23) . Accordingly, we proposed that fibroblasts, like T lymphocytes and endothelial cells, would be stimulated to produce CSA by a factor released by mononuclear phagocytes. In this study we did find that human MCM contains a nondialyzable, heat-stable factor that stimulates fibroblasts to produce CSA (Figs. 1 and 2 ). That these multiply-passaged, spindle shaped cells synthesized types I and III collagen and that T lymphocytes, endothelial cells, and macrophages were not present in these cultures document that MCM interacted with fibroblasts and not with another monokine-responsive cell population. In addition, the production or release of the monokine was markedly inhibited by lactoferrin, a putative feedback regulator of granulopoiesis (6, 16-18)2 (Fig. 1) .
Because CSA measurements involve a colony growth assay, there exists a potential for error when antipodal activities are present in a test medium. Thus, it was possible that potent CSA was present in MCM but masked by an inhibitor of colony growth (e.g., prostaglandin E [24] ) which was lost during the fibroblast cultures. Experiments that effectively ruled out this possibility showed that 10% MCM did not inhibit colony growth of maximally stimulated marrow cells. In addition, dialysis of MCM failed to enhance CSA in MCM. Finally, indomethacin, at doses known to abrogate prostaglandin E synthesis in vitro (23) , failed to augment CSA in MCM or in FCMM. We conclude that there was no inhibitor of clonal growth in MCM that could have accounted for the greater CSA observed in FCMM and that fibroblasts are indeed potent sources of CSA.
Few of the monokines have been characterized biochemically and several biological activities in MCM may represent functions of a single molecule. At this time, we do not know whether the activity observed in our experiments represents a novel monokine or simply an additional activity of a previously described factor. This monokine could, for example, represent the same factor that stimulates CSA production by T lymphocytes (6) and endothelial cells.2 Indeed, there exist some similarities; lactoferrin inhibits the production of the monokine that recruits T lymphocytes (6) and the monokine that stimulates CSA production by endothelial cells is heat stable and nondialyzable. It is possible that this monokine represents an inactive "pro" CSA molecule that fibroblasts (and other cells) activate. However, we do not believe that this activity represents the same factor that stimulates fibroblast proliferation in vitro (21) because in our experiments, MCM failed to stimulate proliferation of fibroblasts. Furthermore, the activity of MCM in confluent fibroblast cultures suggests that target cell proliferation is not required for the CSA-enhancing effect of MCM.
CSA has been widely regarded as a likely candidate for a biologically relevant "granulopoietin" (25, 26) but its role in regulating granulopoiesis in vivo has not been established. Studies on the biological relevance of CSA under steady-state conditions are fraught with conceptual pitfalls. For example, most of the cell types known to produce CSA do so principally when stimulated by exogenous factors such as mitogens (7, 8) or endotoxin (10) , conditions that fail to approximate the steady state. Although it seems reasonable to propose that regulatory cell diversity confers upon a species an evolutionary survival advantage, it has been difficult to accept a major regulatory role for a factor produced independently by such diverse cell types most of which are consistently unresponsive in vitro to neutrophil-derived feedback signals (10, 16) . Although our studies have confirmed the diversity of CSA-producing cell types, we have also demonstrated that the production of CSA by these cells does not occur independently, rather it is under the regulatory control of mononuclear phagocytes.
It should be emphasized that the nonfibroblast target cells of these monokines can be stimulated in other ways to produce CSA (e.g., with endotoxin [10] or mitogens [6, 7] ) and in those settings lactoferrin fails to inhibit CSA production (10, 16) . Inasmuch as these stimuli in vivo result in an increase in neutrophil production, the responsiveness of the CSA-producing cell population to the stimulatory substance would be theoretically expected as would their refractoriness to a neutrophil-derived inhibitor of steady-state granulopoiesis. Therefore, if the lactoferrin-inhibited monokine proves to (6)2 (Fig.  1) . Therefore, although lactoferrin-mediated feedback regulation of neutrophil production in vitro ultimately results in inhibition of CSA production, the effect is an indirect one and results from lactoferrin's inhibition of the recruitment phenomenon. Identification and purification of this potentially regulatory monokine may permit a more accurate analysis of the role played by lactoferrin and other as yet unidentified factors in regulating steady-state granulopoiesis in vivo.
